Suven Life Sciences

Pharma industry seeks financial assistance from government for rare diseases

Read more

Suven Pharmaceuticals financial results – strong show in FY20; outlook upbeat: ICICI Securities

Read more

First patient randomised in a Phase 2A, Proof of Concept (PoC) clinical trial of SUVN-G3031

Read more

Suven receives two product patents from Israel and Mexico

Read more

Suven Life Sciences secures two product patents in Australia and Canada

Read more

Suven Life Sciences secures three product patents

Read more

Suven Life gets patent for neurodegenerative drug

Read more

Suven Life Sciences secures three product patents in Canada and China

Read more

Suven Life Sciences secures five product patents

Read more

Suven Life Sciences’ NCE SUVN-D4010 commences phase I trial in US

Read more